Our Partners

Ethis partners closely with international industry leaders Quint Health (Europe), ESASO (Europe, Middle East, Asia), and CI Service (Japan) in order to provide global expertise to our clients

417153-PD78XB-878.jpg

Global capabilities

Through these partnerships our resulting work has a broader reach, is more comprehensive, and ultimately, more effective or impactful

Whether you’re looking to enter the market, planning an event during an international meeting, or need to provide training abroad, we’ll help

 
ethisweb-Aware_1200x900.png

Quint Health is an ophthalmic pharmaceutical industry consultancy firm. The mission of Quint Health is to define new innovative products and technologies in the international pharmaceutical market. They specialize in new product, regulatory affairs and manufacturing, with a specific emphasis in ophthalmology.

 
 
 
ESASO_1.jpg

European School for Advanced Studies in Ophthalmology (ESASO) was founded in 2008 and has campuses in both Europe and Asia. ESASO’s mission is to provide post-graduate education and disseminate new and effective learning and expertise to improve the clinical and surgical practice of specialists in ophthalmology. The internationally renowned faculty offers hands-on learning in all subspecialties.

 
ethisweb-KOLAlgo_1200x900.png

CI Service, LLC, is dedicated to providing professional service for our business partners in the Japanese market. With vast experience in the pharmaceutical industry (mainly ophthalmology), we can offer you seamless cultural and linguistic access to key opinion leading clinicians and academic centers.

 

AAO_color+(1).png

OIS@AAO | October 10, 2019 – San Francisco, CA

OIS@AAO unites over 1,000 industry, entrepreneurial and clinical leaders to collaborate on the development and commercialization of innovative drugs and devices to address unmet clinical needs.

 
 
 
ASCRS_color+(1).png

OIS@ASCRS | May 14, 2020 – Boston, MA

OIS@ASCRS unites over 600 industry, entrepreneurial and clinical leaders to collaborate on the development and commercialization of innovative drugs and devices to address unmet clinical needs.

 
Picture10.jpg